James H. Quigley - Net Worth and Insider Trading
James H. Quigley Net Worth
The estimated net worth of James H. Quigley is at least $3 Million dollars as of 2024-11-13. James H. Quigley is the Director of Hess Corp and owns about 21,139 shares of Hess Corp (HES) stock worth over $3 Million. James H. Quigley is the Director of Wells Fargo & Co and owns about 2,150 shares of Wells Fargo & Co (WFC) stock worth over $156,090. James H. Quigley is also the Director of Merrimack Pharmaceuticals Inc and owns about 5,650 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $85,485. Details can be seen in James H. Quigley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James H. Quigley has not made any transactions after 2019-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James H. Quigley
James H. Quigley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James H. Quigley owns 3 companies in total, including Hess Corp (HES) , Wells Fargo & Co (WFC) , and Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of James H. Quigley’s form 4 insider trades.
Insider Ownership Summary of James H. Quigley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HES | Hess Corp | 2019-03-06 | director |
| WFC | Wells Fargo & Co | 2016-05-03 | director |
| MACK | Merrimack Pharmaceuticals Inc | 2014-05-19 | director |
James H. Quigley Latest Holdings Summary
James H. Quigley currently owns a total of 3 stocks. Among these stocks, James H. Quigley owns 21,139 shares of Hess Corp (HES) as of March 6, 2019, with a value of $3 Million and a weighting of 92.49%. James H. Quigley owns 2,150 shares of Wells Fargo & Co (WFC) as of May 3, 2016, with a value of $156,090 and a weighting of 4.85%. James H. Quigley also owns 5,650 shares of Merrimack Pharmaceuticals Inc (MACK) as of May 19, 2014, with a value of $85,485 and a weighting of 2.66%.
Latest Holdings of James H. Quigley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HES | Hess Corp | 2019-03-06 | 21,139 | 140.79 | 2,976,160 |
| WFC | Wells Fargo & Co | 2016-05-03 | 2,150 | 72.60 | 156,090 |
| MACK | Merrimack Pharmaceuticals Inc | 2014-05-19 | 5,650 | 15.13 | 85,485 |
Holding Weightings of James H. Quigley
James H. Quigley Form 4 Trading Tracker
According to the SEC Form 4 filings, James H. Quigley has made a total of 0 transactions in Hess Corp (HES) over the past 5 years. The most-recent trade in Hess Corp is the acquisition of 442 shares on March 6, 2019, which cost James H. Quigley around $25,079.
According to the SEC Form 4 filings, James H. Quigley has made a total of 0 transactions in Wells Fargo & Co (WFC) over the past 5 years. The most-recent trade in Wells Fargo & Co is the acquisition of 2,000 shares on May 3, 2016, which cost James H. Quigley around $99,940.
According to the SEC Form 4 filings, James H. Quigley has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 500 shares on May 19, 2014, which cost James H. Quigley around $32,900.
Insider Trading History of James H. Quigley
- 1
James H. Quigley Trading Performance
GuruFocus tracks the stock performance after each of James H. Quigley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James H. Quigley is 4.41%. GuruFocus also compares James H. Quigley's trading performance to market benchmark return within the same time period. The performance of stocks bought by James H. Quigley within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James H. Quigley's insider trading performs compared to the benchmark.
Performance of James H. Quigley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.73 | | | | | |
| Relative Return to S&P 500(%) | 9.39 | | | | | |
James H. Quigley Ownership Network
Ownership Network List of James H. Quigley
Ownership Network Relation of James H. Quigley
James H. Quigley Owned Company Details
What does Hess Corp do?
Who are the key executives at Hess Corp?
James H. Quigley is the director of Hess Corp. Other key executives at Hess Corp include Senior Vice President Geurt G Schoonman , director & 10 percent owner & Chairman of the Board and CEO John B Hess , and Executive Vice President Gregory P. Hill .
Hess Corp (HES) Insider Trades Summary
Over the past 18 months, James H. Quigley made no insider transaction in Hess Corp (HES). Other recent insider transactions involving Hess Corp (HES) include a net sale of 157,918 shares made by Gregory P. Hill , a net sale of 45,628 shares made by Andrew P Slentz , and a net sale of 20,311 shares made by Geurt G Schoonman .
In summary, during the past 3 months, insiders sold 612,550 shares of Hess Corp (HES) in total and bought 0 shares, with a net sale of 612,550 shares. During the past 18 months, 1,009,734 shares of Hess Corp (HES) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,009,734 shares.
Hess Corp (HES)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hess Corp Insider Transactions
James H. Quigley Mailing Address
Above is the net worth, insider trading, and ownership report for James H. Quigley. You might contact James H. Quigley via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
